Sun Pharmaceutical has introduced Fexuclue (fexuprazan 40 mg), a novel potassium-competitive acid blocker, as a new treatment option for adults with all grades of erosive esophagitis in India.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.